A cornea transplant (keratoplasty) is a surgical treatment that involves removing a portion of the cornea and replacing it with corneal tissue from a donor. The transparent, dome-shaped surface of the eye is known as the cornea. It is a large aspect of the eye's ability to see clearly because it is where light enters the eye. A cornea transplant can enhance the appearance of a damaged or diseased cornea while also restoring vision and reducing pain.
The growth of the corneal transplantation market is attributed to the increasing incidence of eye diseases, and the rising geriatric population. However, the risks associated with Corneal Transplantation and shortage of donor material hampers the market growth.
You will get customization on any report - free of charge - including parts of this report, or country-level analysis, Excel Data pack, as well as avail great offers and discounts for start-ups & universities
Corneal Transplantation Market: Strategic Insights
The geriatric patient population is growing rapidly worldwide due to a significant rise in the subset of patients older than 80. According to the US Department of Health and Human Services, 54.1 million people were aged 65 and above in 2019 (up from 39.6 million in 2020). The population will reach 80.8 million by 2040 and 94.7 million by 2060. As the number of geriatric people increases, the demands of this group for healthcare services also continue to grow. The aging of an ocular surface and corneal tissues, and the consequent impairment of visual functions lead to severe eye diseases and a significant impact on vision. The conditions that affect these vital parts of the eye place a critical medical and socioeconomic burden on society. Thus, the increase in the population of elderlies is driving the overall growth of the corneal transplant market.
Based on type, the global corneal transplantation market has been segmented into penetrating keratoplasty, Descemet Membrane Endothelial Keratoplasty (DMEK), Descemet Stripping Endothelial Keratoplasty (DSEK), Corneal Limbal Stem Cell Transplant, and others. The penetrating keratoplasty segment held the largest share of the market in 2021 and is anticipated to register the CAGR of 6.4% in the market during the forecast period.
Based on indication, the global corneal transplantation market is segmented into fungal corneal ulcer, Fuchs dystrophy, keratoconus, keratitis, and others. The Fuchs dystrophy segment held the largest share of the market in 2021 and is anticipated to register a CAGR of 6.8% in the market during the forecast period.
The regional trends and factors influencing the Corneal Transplantation Market throughout the forecast period have been thoroughly explained by the analysts at Insight Partners. This section also discusses Corneal Transplantation Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 420.71 Million |
| Market Size by 2028 | US$ 640.79 Million |
| Global CAGR (2021 - 2028) | 6.2% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By Type
|
| Regions and Countries Covered | North America
|
| Market leaders and key company profiles |
The Corneal Transplantation Market market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.
Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.
Major Companies operating in the Corneal Transplantation Market are:
Disclaimer: The companies listed above are not ranked in any particular order.
Based on end user, the Corneal Transplantations market is segmented hospitals, eye clinics, and ambulatory surgical centers. The hospital segment held the largest share of the market in 2021 and is estimated to register the highest CAGR of 6.1% in the market during the forecast period.
Product launches and approvals are commonly adopted strategies by companies to expand their global footprints and product portfolios. Moreover, the corneal transplantation market players focus on the partnership strategy to expand their clientele, which, in turn, permits them to maintain their brand name across the world.
Corneal transplantation market is segmented by geography into North America, Europe, Asia Pacific, Middle East & Africa, and South and Central America. North America held the largest market share for corneal transplantation. The United States held the largest market in North America for corneal transplantation, and the market is expected to grow due to the rising prevalence of eye diseases such as keratoconus, Fuchs dystrophy, and infectious keratitis. In the USA, a study found a prevalence of 54.5 per 100,000 people. Also, the country has a significantly growing geriatric population, which is expected to lead the corneal transplantation procedures. However, Asia Pacific registered as the fastest-growing region in the global corneal transplantation market. The growth of the corneal transplantations market is expected to grow due to the rising prevalence of eye diseases and related factors. In China, eye diseases such as uncorrected sight problems, limited access to ophthalmologists in rural parts are driving the market growth. Whereas in Japan, the cost of eye health is rising significantly, and in India, the prevalence of diabetic retinopathy is growing exponentially. Also, factors such as the rising geriatric population in South Korea and global initiatives such as Vision 2020 Australia in Australia are likely to support the growth of the market during the forecast period.
Corneal transplantation is a surgical procedure in which a damaged or diseased cornea is replaced with donated corneal tissue. When the entire cornea is replaced, it is called penetrating keratoplasty, and when only part of the cornea is replaced, it is called lamellar keratoplasty (LK).
Key factors that are driving the growth of the corneal transplantation market over years are the increasing incidence of eye diseases and surge in geriatric population.
The penetrating keratoplasty segment dominated the corneal transplantation market and held the largest market share of 46.25% in 2021.
The Fuchs dystrophy segment dominated the corneal transplantation market and held the largest market share of 42.24% in 2021.
The hospitals segment dominated the corneal transplantation market and accounted for the largest revenue share of 51.68% in 2021.
The corneal transplantation market majorly consists of the players such CorneaGen, Alcon Inc., Florida Lions Eye Bank, Corneat Vision, Aurolab, Keramed, Inc., Cornea Biosciences, Inc., Lifeline Scientific, Inc.; Eyemedics, Massachusetts Eye and Ear, and San Diego Eye Bank among others.